Clinical Trial Update: Study of MK0869 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (0869-071)(COMPLETED) [Phase 3]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 3 study of MK0869 for the prevention of chemotherapy-induced nausea and vomiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• MK0869

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Nausea, Vomiting | Phase 3 | Status: COMPLETED